Header Logo

Connection

SUZANNE FUQUA to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications SUZANNE FUQUA has written about Antibodies, Monoclonal, Humanized.
SUZANNE FUQUA
Connection Strength
0.026
Antibodies, Monoclonal, Humanized
  1. Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer. Breast Cancer Res Treat. 2018 02; 167(3):731-740.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.